Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beauty Farm Medical & Health Industry, Inc. ( (HK:2373) ) has issued an update.
Beauty Farm Medical & Health Industry, Inc. has announced a major transaction involving the acquisition of 100% of the issued shares in Shanghai Siyanli Industrial for RMB1,250.0 million. This acquisition will result in Shanghai Siyanli Industrial becoming an indirect wholly-owned subsidiary of Beauty Farm, with its results, assets, and liabilities consolidated into the group’s accounts. The transaction involves the issuance of consideration shares, which will be subject to shareholder approval at an Extraordinary General Meeting (EGM). The acquisition is classified as a major transaction under the Listing Rules, necessitating certain reporting and approval requirements. Shareholders and potential investors are advised to exercise caution as the acquisition is subject to conditions precedent and may not proceed.
The most recent analyst rating on (HK:2373) stock is a Buy with a HK$30.00 price target. To see the full list of analyst forecasts on Beauty Farm Medical & Health Industry, Inc. stock, see the HK:2373 Stock Forecast page.
More about Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical & Health Industry, Inc. operates in the medical and health industry, focusing on providing healthcare services. The company is involved in the acquisition and management of healthcare facilities and services, aiming to expand its market presence and enhance its service offerings.
Average Trading Volume: 422,530
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.48B
Find detailed analytics on 2373 stock on TipRanks’ Stock Analysis page.